Event Type
Disclosure
Mandatory
Variant
8-K
Results of Operations and Financial Condition. On November 13, 2025, Evoke Pharma, Inc. issued a press release announcing its financial results for the three an
Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press Release issued on November 13, 2025 104 Cover Page Interactive Data File (emb